Podiatry Management: an interview with Dr. Jeffrey Adler

08 April 2016 - Trade fairs & Congresses -

The special feature “Profiles in excellence 2016” in the Podiatry Management magazine, reports an interesting interview with Dr. Jeffrey Adler, DPM (Doctor of Podiatric Medicine) and Director of the Adler Footcare podiatric clinic of Greater New York. The doctor, who daily treats issues such as bursitis, plantar fasciitis and post-op problems, talks of MLS® Laser Therapy as the primary method for relieving this type of patients’ pain. His clinic has been equipped with the M6 laser device, supplied by Cutting Edge Laser Technology, the USA ASAlaser distributor, since 2013 and the podiatrist states that 95% of his patients treated with MLS® obtains an 80% pain reduction.
 

You might also be interested in ...

See all articles

Press - 29/11/2018
The press agency Italpress reports the success of the course sponsored by FIS - Federazione Italiana Scherma (Italian Fencing Federation), dedicated to traumatology in sports, with an extensive focus...
Press - 12/10/2018
The ASAlaser “highly technological” devices and the efficient therapeutic solutions are at home for the Taiwan national team (Chinese Taipei) at the Indonesia 2018 Asian Para Games. The...
Press - 08/10/2018
Doctor Alessandro Danieli, in charge of the Fisiodanieli centre, a specialist medical centre in Rome, has no doubts when interviewed by the capital’s magazine “In Roma”, controlled...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.